Trial intelligence / Profile preview

Midazolam versus dexmedetomidine before extubation after lumbar disc surgery

IRCT20210415050976N2Phase 3Completed

Sponsor
Jahrom University of Medical Sciences
Start
May 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in lumbar disc disease comparing Midazolam arm, Dexmedetomidine arm and Placebo arm (3 arms). Primary endpoints: Systolic blood pressure, Diastolic blood pressure and 2 more. Started May 2021; status: completed.

02

Drugs

midazolamdexmedetomidine
03

Conditions

lumbar disc disease

Beyond the preview

Go deeper on IRCT20210415050976N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210415050976N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call